Is Serum Cystatin-C a Reliable Marker for Metabolic Syndrome?

American Journal of Medicine

Volumn 121, Issue 5, 2008, Pages 426-432

  Servais, Aude ^a   Giral, Philippe ^a   Bernard, Maguy ^a   Bruckert, Eric ^a   Deray, Gilbert ^a   Isnard Bagnis, Corinne ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cardiovascular risk; Cystatin C; Glomerular function rate; High blood pressure; Hypertriglyceridemia; Metabolic syndrome; Waist circumference

Indexed keywords

CREATININE; CYSTATIN C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CYSTATINS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 43049123497     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.01.040     Document Type: Article

References (41)

1. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 17 (2005) 2735-2752
2. Haffner S.M. Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns. Am J Med 19 5 Suppl 1 (2006) S3-S9
3. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 4 (2001) 683-689
4. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 21 (2002) 2709-2716
5. Chen J., Muntner P., Hamm L.L., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140 3 (2004) 167-174
6. Chen J., Gu D., Chen C.S., et al. Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant 22 4 (2007) 1100-1106
7. Locatelli F., Pozzoni P., and Del Vecchio L. Renal manifestations in the metabolic syndrome. J Am Soc Nephrol 17 4 Suppl 2 (2006) S81-S85
8. Dharnidharka V.R., Kwon C., and Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40 2 (2002) 221-226
9. Fliser D., and Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 37 1 (2001) 79-83
10. Coll E., Botey A., Alvarez L., et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36 1 (2000) 29-34
11. Finney H., Newman D.J., and Price C.P. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 37 Pt 1 (2000) 49-59
12. Mangge H., Liebmann P., Tanil H., et al. Cystatin C, an early indicator for incipient renal disease in rheumatoid arthritis. Clin Chim Acta 300 1-2 (2000) 195-202
13. Shlipak M.G., Sarnak M.J., Katz R., et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352 20 (2005) 2049-2060
14. Risch L., Drexel H., and Huber A.R. Cystatin C and the risk of death. N Engl J Med 353 8 (2005) 842-844 author reply 842-844
15. Shlipak M.G., Wassel Fyr C.L., Chertow G.M., et al. Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 17 1 (2006) 254-261
16. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 6 (1999) 461-470
17. Erlandsen E.J., Randers E., and Kristensen J.H. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 59 1 (1999) 1-8
18. Dekker J.M., Girman C., Rhodes T., et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 112 5 (2005) 666-673
19. Hu G., Qiao Q., Tuomilehto J., et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164 10 (2004) 1066-1076
20. Shlipak M.G., Katz R., Fried L.F., et al. Cystatin-C and mortality in elderly persons with heart failure. J Am Coll Cardiol 45 2 (2005) 268-271
21. Fried L.F., Katz R., Sarnak M.J., et al. Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 16 12 (2005) 3728-3735
22. Sarnak M.J., Katz R., Stehman-Breen C.O., et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 142 7 (2005) 497-505
23. Ix J.H., Shlipak M.G., Chertow G.M., and Whooley M.A. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 115 2 (2007) 173-179
24. Koenig W., Twardella D., Brenner H., and Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 51 2 (2005) 321-327
25. Risch L., Blumberg A., and Huber A. Rapid and accurate assessment of glomerular filtration rate in patients with renal transplants using serum cystatin C. Nephrol Dial Transplant 14 8 (1999) 1991-1996
26. Meier P., Froidevaux C., Dayer E., and Blanc E. Cystatin C concentration and glomerular filtration rate. Lancet 357 9256 (2001) 634-635
27. Herget-Rosenthal S., Trabold S., Pietruck F., et al. Cystatin C: efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol 20 2 (2000) 97-102
28. Pucci L., Triscornia S., Lucchesi D., et al. Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem 53 (2007) 480-488
29. Shlipak M.G., Fyr C.L., Chertow G.M., et al. Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol 17 1 (2006) 254-261
30. Hoehner C.M., Greenlund K.J., Rith-Najarian S., et al. Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project. J Am Soc Nephrol 13 6 (2002) 1626-1634
31. Chen J., Muntner P., Hamm L.L., et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14 2 (2003) 469-477
32. Tanaka H., Shiohira Y., Uezu Y., et al. Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 69 2 (2006) 369-374
33. Kurella M., Lo J.C., and Chertow G.M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16 7 (2005) 2134-2140
34. Muntner P., Coresh J., Smith J.C., et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 58 1 (2000) 293-301
35. Hunsicker L.G., Adler S., Caggiula A., et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51 6 (1997) 1908-1919
36. Fried L.F., Orchard T.J., and Kasiske B.L. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 59 1 (2001) 260-269
37. Iseki K., Ikemiya Y., Kinjo K., et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65 5 (2004) 1870-1876
38. Fliser D., Kielstein J.T., and Menne J. Insulin resistance and renal disease. Contrib Nephrol 151 (2006) 203-211
39. Eidemak I., Feldt-Rasmussen B., Kanstrup I.L., et al. Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 38 5 (1995) 565-572
40. Kobayashi S., Maesato K., Moriya H., et al. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 45 2 (2005) 275-280
41. Sechi L.A., Catena C., Zingaro L., et al. Abnormalities of glucose metabolism in patients with early renal failure. Diabetes 51 4 (2002) 1226-1232